8-Chloro-2,3,4,5-tetrahydro-1-benzoxepin-5-one, 97%, 250mg

2,4,6-Trimethyl-1,3,5-triazine, 95.0%, 25g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 97.0%, 25g

Citrate tripotassique monohydraté, min.99%, Ph.Eur., USP, 2,5 kg, emballage plastique.

(4-bromo-2-chlorophenoxy)acetic acid, 95.0%, 500mg

1-((2-(Trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridin-2(3H)-one, 95.0%, 1g

6-Methoxy-3-methyl-1H-indazole, 95.0%, 250mg

Phenanthren-3-ol, 95%, 1g

5-Bromo-1-(bromomethyl)-2,3-difluorobenzene, 98%, 100mg

3-fluoro-3'-morpholinomethyl benzophenone, 97.0%, 1g

6-Bromo-5-methoxypyridin-3-amine, 95.0%, 500mg

2-{[4-(3-chloro-4-methylphenyl)-4h-1,2,4-triazol-3-yl]sulfanyl}acetic acid, 97%, 100mg

2-Bromo-4-fluoro-1-(methylthio)benzene, 95.0%, 250mg